Komori
Mitsubishi Chemical Group (4188) · InitiativeAdvancedLatest Financial results presentation (2026-11-05): "Restated"

Strategic investments, including capital expenditure and M&A, in growth businesses

First written in FY2016. 31 of 35 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-11-05.

35entries
11years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017-Q1 – FY2026-H12016: 420162017: 420172018: 420182019: 220192020: 320202021: 420212022: 320222023: 220232024: 320242025: 220252026: 42026
Same theme, other companies
Reinvestment in R&D, Capital Expenditures and M&AA theme 94 companies write about · 0 as a headwind · 94 as a tailwind

31 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 94 companies compared. The sentences above are computed from all 94.
Full recordFilings, disclosures and news, newest first
  1. 2026-11-05RestatedFinancial results presentation

    「配当につきましては、今後の事業展開の原資である内部留保の充実を考慮しつつ、「中期経営計画2029」において、配当性向35%を目安とし、利益成長に応じて配当増加を図ることを目標としております。」

    配当性向35%を目安とし、利益成長に応じて配当を増加させる方針が再掲された。
  2. FY2026AdvancedAnnual report

    「The capital expenditure plan for the 1-year period following the end of the current consolidated fiscal year is ¥339,100 million,」

    Regarding growth and rationalization investments, the capital expenditure plan for the following fiscal year was set at ¥339.1 billion, with specific projects including Soarnol, anode materials, carbon fiber-related facilities and air separation units for the industrial gas business.
  3. FY2026-H1AdvancedAnnual report

    「Through its Australian subsidiary NSC (Australia), the Group acquired the businesses operated by Coregas in Australia and New Zealand effective 1 July 2025.」

    As a strategic investment in growth businesses, the company acquired 100% of the industrial gas businesses in Australia and New Zealand, recording purchase consideration of ¥71,521 million.
  4. FY2025AdvancedAnnual report

    「The capital expenditure plan for the 1-year period following the end of the current consolidated fiscal year is ¥359,000 million, with the breakdown by segment as follows.」

    Regarding capital expenditure in growth businesses, the plan for the following 1-year period was set at ¥359.0 billion, with specific projects including Specialty Materials, anode materials, Soarnol, carbon fiber-related facilities, and hydrogen and steam supply facilities for the industrial gas business.
  5. FY2025-H1AdvancedAnnual report

    「To meet growing demand for ArF and EUV photoresists associated with semiconductor device miniaturization and to strengthen the supply chain, the Company decided to increase production capacity for “リソマックス™,” a photosensitive polymer for photoresists, at its Kyushu Site in the Fukuoka area. Capacity for “リソマックス™” for ArF photoresists will be increased by more than 2 times, and mass production of “リソマックス™” for EUV photoresists will newly begin. Operations are scheduled to begin in October 2025 for “リソマックス™” for ArF photoresists and September 2025 for “リソマックス™” for EUV photoresists.」

    As a growth investment related to semiconductors, the company decided to more than double ArF production capacity for photoresist photosensitive polymers in the Fukuoka area and newly commence mass production for EUV applications.
  6. FY2024AdvancedAnnual report

    「In March 2024, we decided to add a new line with production capacity of 1,100 tonnes per year to the sugar ester manufacturing facility at the Kyushu site, which began operations in March 2024 and has production capacity of 2,000 tonnes per year. The new line is scheduled to begin operations in March 2026.」

    As capital expenditure in growth businesses, the company added a new sugar ester production line with capacity of 1,100 tons per year and announced that operation is scheduled to begin in March 2026.
  7. FY2024-Q3AdvancedAnnual report

    「To strengthen our carbon fiber business, we decided in October 2023 to acquire all shares of C.P.C. S.r.l., an equity-method affiliate that manufactures carbon-fiber-reinforced plastic automotive components and is headquartered in Modena, Italy. The acquisition was completed in January 2024. Through the acquisition of all shares, we will strengthen and expand our vertically integrated supply chain and accelerate the long-term growth of the business.」

    As a strategic investment in growth businesses, the company acquired the remaining shares of C.P.C., in which it had held a 44% stake since 2017, and completed the process of making it a wholly owned subsidiary in January 2024.
  8. FY2024-Q2AdvancedAnnual report

    「Through its subsidiary Mitsubishi Chemical Europe, the Group agreed with the shareholders of C.P.C., a manufacturer and seller of automotive components made from carbon-fiber-reinforced plastic (CFRP), to acquire additional shares. The Group invested 44% in C.P.C. in 2017, making it an equity-method affiliate, but the additional acquisition will make C.P.C. a wholly owned subsidiary and strengthen and expand its vertically integrated supply chain, accelerating the long-term growth of the carbon fiber business. The acquisition is scheduled to be completed at the end of 2023, subject to regulatory approval. The purchase consideration is expected to be approximately €34 million (approximately ¥53.8 billion). • To meet growing demand for LIBs and semiconductors, the company decided to increase γ-butyrolactone production capacity at its Okayama plant from the current 18,000 t per year to 20,000 t per year. Operation is scheduled to begin in July 2024.」

    As investments in growth businesses, the company specified an agreement to acquire additional shares toward making C.P.C. a wholly owned subsidiary, as well as an increase in γ-butyrolactone production capacity at the Okayama plant.
  9. FY2023AdvancedAnnual report

    「The capital expenditure plan for the 1-year period following the end of the current consolidated fiscal year is ¥330,000 million,」

    Regarding capital expenditure in growth businesses, the plan for the following 1-year period was set at ¥330.0 billion, with specific projects including Soarnol expansion, C.P.C.-related facilities, polyester film and hydrogen supply facilities.
  10. FY2023-Q2AdvancedAnnual report

    「To meet growing global demand for food packaging materials, the company decided in July 2022 to increase production capacity in the UK for Soarnol™, an ethylene-vinyl alcohol copolymer resin, from the current 18,000 tonnes per year to 39,000 tonnes per year. Operations are targeted to begin in July 2025.」

    As capital expenditure in growth businesses, the company decided to increase Soarnol production capacity in the United Kingdom from 18,000 tons to 39,000 tons per year, targeting operation in July 2025.
  11. FY2023-Q1AdvancedAnnual report

    「To meet strong demand for anode materials for lithium-ion batteries, the company decided to increase production capacity in China for its newly developed natural-based anode material featuring low expansion, from the current 2,000 tonnes per year to 12,000 tonnes per year. Operations are targeted to begin in the first half of fiscal 2023.」

    As capital expenditure in growth businesses, the company decided to increase production capacity for natural-material anode materials in China sixfold, targeting operation in the first half of fiscal 2023.
  12. FY2022-Q3AdvancedAnnual report

    「三菱ケミカル㈱’s consolidated subsidiary Mitsubishi Polyester Film GmbH (head office: Wiesbaden, Germany) decided to increase production capacity for polyester film, for which global demand is expected to continue growing, from 55,000 tons to 82,000 tons per year in Germany. The target is to bring the expanded capacity into operation by the end of 2024. • To meet strong demand and strengthen the supply chain, 三菱ケミカル㈱ decided in December 2021 to establish a new production site for specialty epoxy resins for semiconductor encapsulants and electronic materials at its Fukuoka plant in Kitakyushu, Fukuoka Prefecture. Commercial production is targeted to begin in April 2023. • 日本酸素ホールディングス㈱ decided in November 2021 to progressively increase production capacity for diborane gas, an electronic material gas used in semiconductor manufacturing processes, in Japan, South Korea and China by the end of 2023.」

    Regarding capital expenditure in growth businesses, the company newly specified plans to increase polyester film production capacity in Germany from 55,000 tons to 82,000 tons per year, establish a specialty epoxy resin production site in Fukuoka, and increase diborane gas production capacity in Japan, South Korea and China.
  13. FY2022-Q2AdvancedAnnual report

    「• In April 2021, 日本ポリケム㈱, a consolidated subsidiary of 三菱ケミカル㈱, decided to acquire shares in 6 overseas group companies, including Mytex Polymers US, headquartered in Indiana, United States, which is owned by 日本ポリプロ㈱, a joint venture with JNC石油化学株式会社, and operates polypropylene compound and glass-long-fiber-reinforced thermoplastic resin businesses. The companies became wholly owned subsidiaries in July of the same year. • To meet increased demand and strengthen the supply chain, 三菱ケミカル㈱ decided to construct new production facilities for sugar esters at its Fukuoka plant in Kitakyushu, Fukuoka Prefecture, with production capacity of 2,000 tons per year. The target is to commence operation in mid-2023.」

    As growth investments, the company made 6 overseas group companies involved in materials related to vehicle weight reduction wholly owned subsidiaries in July 2021. It also decided to construct new sugar ester facilities with production capacity of 2,000 tons per year, targeting operation in mid-2023.
  14. FY2022-Q1AdvancedAnnual report

    「• In April 2021, 日本ポリケム㈱, a consolidated subsidiary of 三菱ケミカル㈱, decided to acquire shares in 6 overseas group companies, including Mytex Polymers US, located in Indiana, United States, which is owned by 日本ポリプロ㈱, a joint venture with JNC石油化学株式会社, and operates polypropylene compound and glass-long-fiber-reinforced thermoplastic resin businesses. The companies became wholly owned subsidiaries in July of the same year. The company will accelerate growth by leveraging its technological capabilities and business platforms in Japan and overseas to meet increased demand for high-performance materials that contribute to vehicle weight reduction.」

    To drive growth in materials related to vehicle weight reduction, the company decided to acquire 6 overseas group companies and completed the process of making them wholly owned subsidiaries in July of the same year.
  15. FY2022-Q1AdvancedAnnual report

    「• To strengthen and expand its carbon fiber and composite materials business, 三菱ケミカル㈱ decided in April 2021 to make capital investments at C.P.C., its equity-method affiliate and a manufacturer and seller of carbon-fiber-reinforced plastic automotive components in Modena, Italy, including the addition of a large press-molding machine with a capacity of 5,000 tons, one of the largest in the world. The target is to bring the equipment into operation during 2023.」

    As capital expenditure in the carbon fiber and composite materials business, the company decided to add a large press-molding machine with a capacity of 5,000 tons at C.P.C., targeting operation during 2023.
  16. FY2021AdvancedAnnual report

    「Under the new medium-term management plan, APTSIS25, the Group plans to allocate the funds it has raised during Step1, from fiscal 2021 to fiscal 2022, as follows: ¥450 billion for capital expenditures, ¥100 billion for investments and loans, and ¥300 billion for R&D investment. Before making investments, however, the Group is carefully assessing the business environment and other factors.」

    Regarding APTSIS25 Step1, the company specified its resource allocation plan for fiscal 2021–2022: ¥450.0 billion in capital expenditure, ¥100.0 billion in investments and loans, and ¥300.0 billion in R&D investment.
  17. FY2021-Q2AdvancedAnnual report

    「To acquire Gelest, a US manufacturer of silicon chemicals and metal compounds, 三菱ケミカル㈱ acquired all shares of Gelest Intermediate Holdings, which controls Gelest, through its subsidiary Mitsubishi Chemical America effective 1 October 2020. Gelest thereby became a consolidated subsidiary of the company.」

    As a strategic investment in growth businesses, the company acquired 100% of Gelest, a manufacturer of silicon chemicals and metal compounds, making it a consolidated subsidiary. The purchase consideration was US$268 million (¥28.3 billion).
  18. FY2020AdvancedAnnual report

    「The company decided to acquire Gelest, a US manufacturer of silicon chemicals and metal compounds, through its subsidiary Mitsubishi Chemical America. Mitsubishi Chemical America signed a share transfer agreement with Gelest’s shareholders on 30 April 2020 to acquire all shares of Gelest Intermediate Holdings, which controls Gelest. The acquisition is scheduled to be completed within approximately 6 months of the agreement date.」

    As an event after the filing date, the company signed an agreement to acquire control of US-based Gelest and is proceeding with investment in silicon chemicals and metal compounds.
  19. FY2020AdvancedAnnual report

    「Under the medium-term management plan “APTSIS20,” the Group plans to allocate funds raised during fiscal 2016 through fiscal 2020 as follows: ¥1.0 trillion to capital expenditure, including ¥500.0 billion for growth; ¥1.3 trillion to investments and loans; and ¥700.0 billion to R&D investment.」

    Regarding growth investments, the company specifically disclosed the planned amounts for capital expenditure, investments and loans, and R&D investment from fiscal 2016 through fiscal 2020.
  20. FY2019AdvancedAnnual report

    「The capital expenditure plan for the 1-year period following the end of the current consolidated fiscal year is ¥298,000 million, comprising ¥90,000 million for Functional Products, ¥62,000 million for Chemicals, ¥104,000 million for Industrial Gases and ¥32,000 million for Healthcare, among other items.」

    Capital expenditure in growth businesses will continue, and the capital expenditure plan for the following 1-year period was increased to ¥298.0 billion.
  21. FY2019-Q3AdvancedAnnual report

    「大陽日酸㈱, a consolidated subsidiary of the Company, acquired Praxair’s European business on 3 December 2018 through its subsidiaries Nippon Gases Euro-Holding and others. Total consideration paid 637,204」

    As a strategic investment in growth businesses, the acquisition of Praxair’s European business was completed, with ¥637.204 billion paid. Following the acquisition, revenue of ¥12,687 million and quarterly profit of ¥286 million have been included from the third quarter.
  22. FY2019-Q2AdvancedAnnual report

    「In August 2018, 三菱ケミカル㈱ entered into an agreement with the shareholders of Cleanpart Group to acquire all of the company’s shares. Cleanpart Group provides precision cleaning and coating services for semiconductor manufacturing equipment to semiconductor manufacturers in Europe and the United States.」

    As a strategic investment in growth businesses, a new agreement was signed to acquire all shares of Cleanpart Group, which operates semiconductor-related services.
  23. FY2019-Q1AdvancedAnnual report

    「This acquisition represents an excellent investment opportunity with strategic significance, providing a major step forward toward realizing this vision.」

    As a strategic investment in growth businesses, 大陽日酸 signed an agreement to acquire Praxair’s European business. The purchase consideration is €5,000 million (approximately ¥643.8 billion), with completion scheduled for November 2018.
  24. FY2018AdvancedAnnual report

    「The capital expenditure plan for the 1-year period following the end of the current consolidated fiscal year is ¥264,000 million, with the breakdown by segment as follows.」

    Capital expenditure in growth areas will continue, with capital expenditure of ¥225,189 million in the current fiscal year and a plan of ¥264.0 billion for the following 1-year period. Major projects include the construction and expansion of polyester film, polypropylene and air separation facilities.
  25. FY2018-Q3AdvancedAnnual report

    「• In October 2017, Mitsubishi Chemical Carbon Fiber and Composites (Europe), a consolidated subsidiary of 三菱ケミカル㈱, signed a share transfer agreement to acquire a 44% stake in C.P.C. (Italy), a manufacturer and seller of carbon-fiber-reinforced plastic automotive components. • In November 2017, 田辺三菱製薬㈱ signed a share transfer agreement to acquire ㈱ステリック再生医科学研究所, which conducts pharmaceutical research and development.」

    As strategic investments in growth businesses, new agreements were signed to acquire a 44% stake in a carbon-fiber-reinforced plastic automotive components company and to acquire a pharmaceutical research and development company.
  26. FY2018-Q2AdvancedAnnual report

    「On 18 October 2017, the company’s consolidated subsidiary 田辺三菱製薬㈱ acquired all issued and issuable shares of NeuroDerm, including shares subject to stock options, making NeuroDerm a wholly owned subsidiary of 田辺三菱製薬㈱. Percentage of voting equity interest acquired: 100%」

    The acquisition of NeuroDerm planned in the previous filing was completed on 18 October 2017, making it a wholly owned subsidiary. The company disclosed purchase consideration of US$1,117 million (¥124.4 billion).
  27. FY2018-Q1AdvancedAnnual report

    「The company’s consolidated subsidiary 田辺三菱製薬㈱ agreed with NeuroDerm on 24 July 2017 to commence acquisition procedures to make NeuroDerm a wholly owned subsidiary. Scheduled timing of share acquisition: October 2017 Percentage of voting equity interest to be acquired: 100% The company plans to pay purchase consideration of US$1,117 million (¥124.1 billion) at closing.」

    As a strategic investment in growth businesses, 田辺三菱製薬 agreed to acquire 100% of NeuroDerm. The acquisition was scheduled for October 2017 and was subject to shareholder approval and other conditions.
  28. FY2017AdvancedAnnual report

    「Under the medium-term management plan “APTSIS 20,” the Group is proceeding with investments for growth in fiscal 2016, including the acquisition of all shares of 日本合成化学工業㈱ and the acquisition of industrial gas businesses and assets in the United States.」

    Regarding strategic investments, including M&A, in growth businesses, the company lists the acquisition of all shares of 日本合成化学工業 and the acquisition of US industrial gas businesses and assets as achievements for fiscal 2016.
  29. FY2017-Q3AdvancedAnnual report

    「The company’s consolidated subsidiary 大陽日酸㈱ acquired the Australian industrial gas and LPG company Supagas Holdings through its subsidiary TNSC (Australia), making Supagas Holdings a consolidated subsidiary of the company. Total purchase consideration: 21,828」

    As a strategic investment in growth businesses, the acquisition of an Australian industrial gas and LPG company was completed, with total purchase consideration of ¥21,828 million recorded.
  30. FY2017-Q2AdvancedAnnual report

    「Total purchase consideration: 77,000」

    As a strategic investment in growth businesses, the acquisition of a US industrial gas business was completed at a purchase consideration of ¥77.0 billion. Interest-bearing debt was ¥1.5632 trillion as of the end of the second quarter of the current consolidated accounting period, down ¥16.4 billion from the end of the previous consolidated fiscal year.
  31. FY2017-Q1AdvancedAnnual report

    「As of the end of the first quarter of the current consolidated accounting period, interest-bearing debt was ¥1.5229 trillion, down ¥56.7 billion from the end of the previous consolidated fiscal year.」

    Regarding efforts to strengthen the financial position and reduce interest-bearing debt, the company disclosed that interest-bearing debt at the end of the quarter had declined by ¥56.7 billion from the end of the previous fiscal year.
  32. FY2017-Q1AdvancedAnnual report

    「In May 2016, Quadrant, a consolidated subsidiary of Mitsubishi Plastics, Inc., entered into a share purchase agreement to acquire all shares of Piper Plastics, a manufacturer of processed engineering plastics.」

    As a strategic investment in growth businesses, an agreement was signed for Quadrant to acquire all shares of Piper Plastics.
  33. FY2016First statedAnnual report

    「Taking the current business environment into account, retained earnings will be allocated under the basic strategy set out in APTSIS 20 to reduce interest-bearing debt in order to strengthen our financial position and to fund growth investments, including capital expenditure and strategic investments such as M&A.」

    The uses of retained earnings include both the reduction of interest-bearing debt and capital expenditure and M&A in growth businesses.
Moved together

"Portfolio and Structural Reform of the Petrochemicals Business" moved the same way as this thread, in the same document, in 21 of its 32 moves.

211515141410★123456
  1. ★This thread
  2. 1Portfolio and Structural Reform of the Petrochemicals Business21×
  3. 2Building an Australia and Oceania platform through the acquisition of an industrial-gases business15×
  4. 3Developing next-generation businesses and pursuing open, shared development15×
  5. 4Improving profitability through cost reductions and asset reduction14×
  6. 5Innovation and joint research centred on R&D14×
  7. 6Funding risks from interest-bearing debt, interest rates and credit-rating downgrades10×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Mitsubishi Chemical Group yet. It last moved in the Financial results presentation of 2026-11-05: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.